Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Validation of Blood Volume Fraction Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscle

  • Stefan Hindel ,

    stefan.hindel@uni-due.de

    Affiliation Department of Radiotherapy, Medical Physics, University Hospital Essen, Essen, North Rhine-Westphalia, Germany

    ORCID http://orcid.org/0000-0003-0902-4503

  • Anika Söhner,

    Affiliation Department of Radiotherapy, Medical Physics, University Hospital Essen, Essen, North Rhine-Westphalia, Germany

  • Marc Maaß,

    Affiliation Department of General and Visceral Surgery at Evangelical Hospital Wesel, Wesel, North Rhine-Westphalia, Germany

  • Wolfgang Sauerwein,

    Affiliation Department of Radiotherapy, Medical Physics, University Hospital Essen, Essen, North Rhine-Westphalia, Germany

  • Dorothe Möllmann,

    Affiliation Department of Pathology, University Hospital Essen, Essen, North Rhine-Westphalia, Germany

  • Hideo Andreas Baba,

    Affiliation Department of Pathology, University Hospital Essen, Essen, North Rhine-Westphalia, Germany

  • Martin Kramer,

    Affiliation Hospital of Veterinary Medicine, Department of Small Animal Surgery, Justus Liebig University Giessen, Giessen, Hesse, Germany

  • Lutz Lüdemann

    Affiliation Department of Radiotherapy, Medical Physics, University Hospital Essen, Essen, North Rhine-Westphalia, Germany

Validation of Blood Volume Fraction Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscle

  • Stefan Hindel, 
  • Anika Söhner, 
  • Marc Maaß, 
  • Wolfgang Sauerwein, 
  • Dorothe Möllmann, 
  • Hideo Andreas Baba, 
  • Martin Kramer, 
  • Lutz Lüdemann
PLOS
x

Abstract

The purpose of this study was to assess the accuracy of fractional blood volume (vb) estimates in low-perfused and low-vascularized tissue using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). The results of different MRI methods were compared with histology to evaluate the accuracy of these methods under clinical conditions. vb was estimated by DCE-MRI using a 3D gradient echo sequence with k-space undersampling in five muscle groups in the hind leg of 9 female pigs. Two gadolinium-based contrast agents (CA) were used: a rapidly extravasating, extracellular, gadolinium-based, low-molecular-weight contrast agent (LMCA, gadoterate meglumine) and an extracellular, gadolinium-based, albumin-binding, slowly extravasating blood pool contrast agent (BPCA, gadofosveset trisodium). LMCA data were evaluated using the extended Tofts model (ETM) and the two-compartment exchange model (2CXM). The images acquired with administration of the BPCA were used to evaluate the accuracy of vb estimation with a bolus deconvolution technique (BD) and a method we call equilibrium MRI (EqMRI). The latter calculates the ratio of the magnitude of the relaxation rate change in the tissue curve at an approximate equilibrium state to the height of the same area of the arterial input function (AIF). Immunohistochemical staining with isolectin was used to label endothelium. A light microscope was used to estimate the fractional vascular area by relating the vascular region to the total tissue region (immunohistochemical vessel staining, IHVS). In addition, the percentage fraction of vascular volume was determined by multiplying the microvascular density (MVD) with the average estimated capillary lumen, , where d = 8μm is the assumed capillary diameter (microvascular density estimation, MVDE). Except for ETM values, highly significant correlations were found between most of the MRI methods investigated. In the cranial thigh, for example, the vb medians (interquartile range, IQRs) of IHVS, MVDE, BD, EqMRI, 2CXM and ETM were vb = 0.7(0.3)%, 1.1(0.4)%, 1.1(0.4)%, 1.4(0.3)%, 1.2(1.8)% and 0.1(0.2)%, respectively. Variances, expressed by the difference between third and first quartiles (IQR) were highest for the 2CXM for all muscle groups. High correlations between the values in four muscle groups—medial, cranial, lateral thigh and lower leg - estimated with MRI and histology were found between BD and EqMRI, MVDE and 2CXM and IHVS and ETM. Except for the ETM, no significant differences between the vb medians of all MRI methods were revealed with the Wilcoxon rank sum test. The same holds for all muscle regions using the 2CXM and MVDE. Except for cranial thigh muscle, no significant difference was found between EqMRI and MVDE. And except for the cranial thigh and the lower leg muscle, there was also no significant difference between the vb medians of BD and MVDE. Overall, there was good vb agreement between histology and the BPCA MRI methods and the 2CXM LMCA approach with the exception of the ETM method. Although LMCA models have the advantage of providing excellent curve fits and can in principle determine more physiological parameters than BPCA methods, they yield more inaccurate results.

Introduction

Capillaries form a microvascular network that supplies the tissue with nutrients. Changes in microcirculation can be used as a diagnostic indicator of abnormal lesions and to optimize the treatment of disease [1]. For example, the fractional tissue blood volume, vb, which is defined as the volume fraction inside the capillary bed [2], represents one of the most valuable parameters for noninvasive tumor grading and can be estimated using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) [3, 4].

DCE-MRI can be performed with different MRI sequence settings and contrast agents, thus enabling detailed assessment of microvascular integrity [5, 6]. This MRI technique enables diagnostic estimation of individual tumor vessel parameters and assessment of the response of tumor vessels to various forms of therapy [7, 8]. Using intravascular contrast agents (also called blood pool contrast agents, BPCA), vb, and blood flow inside a voxel can be estimated. BPCA have the advantage that short acquisitions of 1-2 minutes are sufficient to determine vascular parameters. Imaging with well-established extravasating contrast agents (low-molecular contrast agents, LMCA) on the other hand require about ten minutes to acquire meaningful data [2].

DCE-MRI using LMCA enables determination of the interstitial volume fraction and permeability surface area product and other parameters. So far, the most widely used pharmacokinetic model applied to data of this kind in clinical routine is the extended Tofts model [9]. However, it has the disadvantage of not taking into account the dispersion of the contrast agent bolus while passing through the vascular system, which results in considerable underestimation of blood volume [10, 11]. Moreover, its parameter, Ktrans, combines various types of essential information on tissues structure and function into a single quantity.

Combined administration of an LMCA and a BPCA has the potential to separate more accurately the relevant physiological transport processes (perfusion and permeation) [2, 12, 13]. Improvement of MRI scanner hardware and image reconstruction software has led to an increase in image quality and temporal resolution combined with good spatial coverage, which makes an evaluation of more complicated models conceivable, e.g., the two-compartment exchange model (2CXM) [1, 2]. More elaborate models presumably describe the microvascular tissue structure and function more realistically and are likely to provide more detailed and reliable information on tumor pathophysiology.

Abnormal formation of new vessels by sprouting or splitting processes (neoangiogenesis), initiated by growth proteins secreted by the tumor for the sole purposes of its own nutrient supply, leads to an anarchistic vascular organization of largely dilated microvessels accompanied by significantly increased arteriovenous shunt flow [1315]. The degree of angiogenesis is an essential biomarker providing information on the activity and malignancy of brain tumors [16]. Increasing density of tumor neovascularization is a prominent sign of increasing histological grade and progression of many types of tumors. Histologically, neovascularization is quantified by measurement of microvascular density [17].

Microvascular blood volume has become important in the study of tissue malignancy in low-perfused organs such as skeletal muscle and the breast [13, 1820] as well as in highly perfused brain tumors [3, 4, 2127]. Preclinical BPCA-DCE-MRI results suggest that tumor vascular permeability or tumor blood volume clearly correlates with tumor grade and tumor angiogenesis, as estimated by histological microvascular density quantification, and with tumor response to anti-angiogenic therapy [28]. In addition, the endothelial walls of tumor vessels become more permeable. Therefore, the simultaneous determination of endothelial permeability and tumor blood volume in a single test in the same subject is desirable.

In vivo studies of the well-described skeletal muscle of large mammals with DCE-MRI provide detailed insights into the contrast enhancement of low-perfused tissue, and thus provide a clearer understanding of the functional and structural composition of its tissue architecture. The findings from well-reproducible studies in healthy homogeneous tissue constitute an essential reference for the clinical detection and characterization of malignant tissue in humans. In particular, the pig is a well-suited biomedical non-rodent model for the pharmacokinetics of the human microvasculature because it shares various physiological similarities with humans, especially with regard to its cardiovascular system [29]. Pig hearts are about the same size as human hearts, and coronary blood flow, hemodynamics, and myocardial contractility are similar [30]. Moreover, using domestic pigs as a model allows choosing animals with a body weight similar to humans to ensure maximum comparability. Thus, in the present study, swine skeletal muscle was used to validate the ability of pharmacokinetic DCE-MRI models to quantify the blood volume fraction.

Materials and Methods

Animals

In the present study, 14 adult female pigs (German Landrace or hybrid form; age: approximately 20 weeks; body weight: 56 to 67 kg; no food restriction) were sacrificed. Before this study, another 6 pigs were used to develop and optimize the surgical technique [31] and to establish optimal DCE-MRI and anatomical MR imaging protocols. Two or three animals at a time were bought from a local pig breeding farm. Two weeks before the experiments they were housed together in a 20 square meter vivarium with species-appropriate entertainment facilities. Only healthy animals without known cardiovascular or musculoskeletal disorders were used. The pigs were not fed overnight prior to the experiment but had free access to water. The local institutional ethics committee, the Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen (Approval No. 84-02.04.2012.A208), authorized the animal study, and all experiments were performed in accordance with the German Animal Protection Act. An MRI-compatible monitoring device (Veris, Medrad, Germany) was used for monitoring heart rate and oxygen saturation. None of the pigs woke up during any phase of the experiments. At the end of the experiment, the pig was euthanized under a higher anesthetic dose and by the injection of T61 (0.3 mL/kg).

Surgical Technique and Histology

All surgical procedures were performed, under aseptic conditions, in an operating room equipped for large animals. The pigs were premedicated via an intra- muscular injection of 30 mg/kg ketamine (ketamine 10%, Ceva Tiergesundheit GmbH, Germany), 2 mg/kg azaperone (Stresnil Janssen-Cilag GmbH, Germany), and 0.02–0.05 mg/kg atropine sulfate (Atropinsulfat, B. Braun Melsungen AG, Germany). A peripheral 20-G venous catheter was placed in a ear vein and, approximately 30 min after premedication, total intravenous anesthesia was initiated. A perfusor was used to inject 4-7 mg/kg/h propofol (Propofol-ratiopharm, Ratiopharm, Germany), 0.1-0.5 mg/kg/h midazolam (midazolam injection solution 0.5%, Germany), and 0.0015 mg/kg/h fentanyl (fentanyl citrate solution 3.9 mL/50 mL, Germany). A tracheal tube was placed (Hi-Contour cuffed tracheal tube, ID 8.0, Mallinckrodt, Ireland), and the pig was ventilated with a respiratory device (Fabius, Draeger, Germany). The tidal volume was set at 10 mL/kg, the respiratory rate at 12-14 breaths/min, and the positive end-expiratory pressure at 5 mbar. The tidal volume and frequency were adjusted to keep end-expiratory CO2 within 35-40 mmHg and to maintain at least 95% peripheral oxygen saturation. A central venous catheter (3-Lumen-ZVK-Set, ARROWgard Blue, Arrow, Germany) was placed in the jugular vein on the right side of the neck; the central venous catheter was used for administration of the contrast agent (CA).

In six experiments, MRI acquisitions were followed by obtaining muscle biopsies (1 × 1 × 1 cm) from the lateral (biceps femoris muscle), the cranial (rectus femoris muscle) and the medial (gracilis muscle and adductors) thigh muscles and from the lower leg muscle (gastrocnemius muscle). Except of one, these experiments were no subset of the MRI experiments. The tissue samples were fixed in formaldehyde (4.5%), embedded in paraffin and cut with a rotary microtome (HM355S, Microm International GmbH, Walldorf, Germany) into 2-3 μm-thick sections.

Vascular endothelium was labeled using immunohistochemical staining with isolectin. The sections were deparaffinized in xylene and rehydrated in a descending alcohol series (100%, 95%, 70%) and tap water. Subsequently, the sections were placed in a 3% solution of H2O2 for 10 min and rinsed with wash buffer (DCS Innovative Diagnostik-Systeme Dr. Christian Sartori GmbH & Co. KG, Hamburg, Germany). This step was followed by a protein block with 10% donkey normal serum (DNS) in Dako Real Antibody Diluent (Dako Deutschland GmbH, Hamburg, Germany) for 60 min at room temperature. The sections were rinsed with wash buffer and stored at 4°C over night in a solution of isolectin (Biotinylated Bandeiraea simplicifolia lectin I Isolectin B4, Vector Laboratories, inc., Burlingame, USA) at a dilution of 1:100 or 1:500 with block buffer (10% DNS in Dako Real Antibody Diluent). After rinsing with wash buffer, the sections were overlayed for 45 min with streptavidin-HRP (Dianova GmbH, Hamburg, Germany) at a dilution of 1: 500 and then rinsed again. After that the sections were placed in diaminobenzidine (DAB) solution twice for five minutes and again rinsed with wash buffer. This was followed by counterstaining with hematoxylin and blueing under running tap water. The sections were dehydrated in ascending alcohol series (70%, 95%, 100%) and xylene and covered with Entellan (Merck, Darmstadt, Germany).

The samples were examined with a light microscope (Zeiss Axioplan, Carl Zeiss Microscopy GmbH, Jena, Germany). From each muscle section, 20 images (magnification 400×) were taken with a special camera. Images were taken randomly in a meandering manner, selecting only low-artifact fields of view, where possible without breaks or overlays. This was followed by semiautomatic analysis of the images with the microscope’s morphometry software (Zeiss Axio Vision, Axio Vs40 4.6.3.0, Jena, Germany).

Immunohistochemical Vessel Staining Estimation Method.

The images of isolectin-stained sections were segmented using a first threshold set to label the whole tissue area including muscle cells, connective tissue, vessels, vessel lumina and other tissue structures. The tissue area was determined. A second threshold was set to label brown-colored endothelial cells (Fig 1). Manual correction was performed to include vessel lumina while excluding falsely detected areas such as cell nuclei. The area, number and diameter of the vessels were determined. S1 File

thumbnail
Fig 1. Light microscopy image of a histological preparation from the medial thigh muscle with vascular endothelium stained brown by isolectin.

The selection was performed by semiautomatic analysis of the images with the microscope’s morphometry software to determine the area, number and diameter of the vessels. The outer borders of the segmented vessels are labeled in green.

https://doi.org/10.1371/journal.pone.0170841.g001

Parameter analysis was performed using Microsoft Excel 2010 (Microsoft, Washington, United States). First, the total tissue area was determined. The tissue areas composed of muscle cells, connective tissue, vessels and their lumina, and other tissue structures were determined in square microns using the morphometry software. Note that paraffin embedding leads to tissue shrinkage and makes intercellular spaces appear larger.

Thus, the fluid-filled portions of the intercellular spaces cannot be determined reliably. In a previous study, the percentage of interstitial fluid space (IFS) in frozen sections was determined [32]. We added this value to the morphometrically determined tissue area in this study to obtain the total tissue area. Then the percentage of the vascular area of the total tissue area was determined. The diameter of the vessels was calculated by the morphometry software in microns. Since tissue processing is associated with approx. 20% shrinkage [33], this shrinkage loss was added to the output value. In the following, we refer to this method of histological blood volume determination as immunohistochemical vessel staining (IHVS).

Microvascular Density Estimation Method.

Using the sites of the vessels determined for IHVS, microvascular density (MVD) was calculated as the number of these vessels per square micrometer. For a second method to estimate the fractional blood volume histologically, the MVD was used to estimate the true vascular lumen. The MVD was multiplied by the average estimated capillary lumen, (d/2)2π, given by the mean capillary diameter, d, assumed to be d = 8μm [34]. In the following, we refer to this method as microvascular density estimation (MVDE).

MRI Technique

The pig was positioned supine on the scanner table. The MR scanner table had a built-in 32-channel coil (Siemens Magnetom Aera 1.5 T, Siemens Healthcare, Erlangen, Germany). A body surface coil (array body coil, 18 RF channels, Siemens Healthcare, Erlangen, Germany) was placed on the lower body of the pig. Heart rate and oxygen saturation were monitored with an MR-compatible device (Veris, Medrad, Germany).

Nine of the 14 pigs were investigated using MRI methods to estimate fractional blood volume. To create relaxation-rate-change-time curves, baseline magnetization and relaxation rates were determined before each dynamic acquisition using a T1w 3D gradient echo sequence (TWIST, Siemens Healthcare, Erlangen, Germany) with different flip angles (α = 5°, 10°, 20°, and 30°). The sequence parameters were: TR = 2.69 ms, TE = 0.86 ms, voxel size: 2.9 × 2.9 × 4.5mm3, 160 × 128 × 48 reconstruction matrix, frequency encoding in the axial direction, parallel imaging (GRAPPA) in 3D with 32 central k-space lines and an acceleration factor of 6. The central k-space region was 100%, i.e., k-space sharing was not used for the baseline acquisitions. To improve reproducibility of signal recordings, automatic sequence adjustments were turned off.

The subsequent first 100 dynamic acquisitions were performed using both, peripheral recording density and a central region of 20% each. The other settings were the same as for the baseline acquisitions, except flip angle α = 30°. k-space sharing ensured a temporal resolution of approx. 1.5 sec. The LMCA (Dotarem, Gadoteric Acid, 0.5 mmol/mL, molecular weight 0.56 kDa, Guerbet, France, 0.2 mL/kg body weight) was administered at an injection rate of 5 mL/sec during the dynamic scan starting after acquisition of the fifth image and was directly followed by a 20 mL saline flush injected at the same rate. The 100 3D GRE acquisitions with high temporal resolution were followed by 250 acquisitions with a read-out fraction of the central k-space of 50% and an identical peripheral k-space sampling density. These settings resulted in a lower temporal resolution (approx. 3.5 sec) for the wash-out of the LMCA.

After each acquisition with LMCA we performed a BPCA acquisition using the same sequence settings as before. After the fifth acquisition of the first dynamic sequence, 0.1 mL/kg body weight BPCA (0.25 mMol/mL gadofosveset trisodium, Vasovist Bayer Schering, Berlin, Germany/Ablavar, Lantheus Medical Imaging, Inc., USA) was injected via the central venous catheter at a flow rate of 5 mL/s followed by 20 mL saline using the same injection rate. The molecular weight of the active chelate is 957 Da, but bonding of the contrast agent to serum albumin effectively increases the molecular weight to 68 kDa, resulting in a compound with macromolecular properties [35, 36]. More details of the entire experimental setup can be found elsewhere [31, 32].

Image Data Processing

The baseline 3D GRE images acquired with different flip angles were used to determine baseline longitudinal relaxation rate (R10) and magnetization (M0). Together with the k-space-shared dynamic acquisitions, the time-dependent 3D relaxation rate change maps ΔR1(t) were generated using the method of Li et al. [37]. ΔR1(t) was assumed to be proportional to the time-dependent contrast agent concentration. S2 File

To avoid partial volume effects, the estimated arterial input function (AIF), , was determined from voxels that definitely were completely in the abdominal aorta. The AIF volume of interest consisted of approx. 20 voxels with a total volume of approx. 750 mm3.

Morphological images and the pre- and post-LMCA difference images (T1-TSE) and the dynamic GRE images with local contrast agent administration were used for contouring the medial thigh muscle. For tracer kinetic modeling, averaged relaxation rate change time curves of these virtually segmented muscle regions were used.

We used the Amira Dev 5.2 visualization package (Mercury Computer Systems, Berlin, Germany) on a Debian Linux 64 bit workstation with eight 3.4 GHz processors and 16 GB RAM for virtual segmentation of the muscle area of interest and for calculation of the relaxation rate change time curves. The functionality of Amira 5.2 has been extended for the applicability of software packages that are included as link libraries in AmiraDev.

Blood Volume Quantification Methods

Four different methods of blood volume quantification were applied—two using BPCA and two LMCA. They are briefly described in the following paragraphs. For detailed information we refer to the literature.

Extended Tofts Model (ETM).

The extended Tofts model is described in detail in [1, 2, 9]. It is mathematically described as follows: (1) where ct(t) and ca(t) are the concentration-time curves of the tissue of interest and of the blood plasma of the artery supplying the tissue, respectively. vp, is the fractional plasma volume. In case of a compartimental description [38]: (2)

The permeability-surface product, PS, describes the exchange of the CA between the vascular and the interstitial compartment over the endothelial barrier. The transfer constant from the interstitial space back to the blood plasma, kep, is defined as follows: (3)

Here, ve is the interstitial volume fraction. Plasma perfusion Fp is related to blood perfusion F by the relationship Fp = F ⋅ (1 − Hctt), where Hctt is the microvascular or tissue hematocrit level.

For LMCA data, we used the estimated arterial input function, , measured in the aorta, to calculate the arterial plasma concentration also known as arterial input function, ca(t), at the inlet of the vascular compartment of the tissue of interest, taking into account a time delay Δt: (4)

Fig 2a) shows an example of the corrected AIF measured in the abdominal aorta with use of LMCA. The arterial blood concentration, ca,b(t), is directly related to the arterial plasma concentration, ca(t), by the arterial hematocrit level: ca,b(t) = ca ⋅ (1 − Hcta) ([2]). For the arterial blood of the pig, we used an estimated value of Hcta = 0.4 ([39, 40]). The concentration-time curve in the tissue of interest is given by ct(t), and the fractional plasma volume, vp, is related to the fractional blood volume by the relationship vp = vb ⋅ (1 − Hctt). In this study, we assumed the level of microvascular or tissue hematocrit, Hctt = 0.2, to be 50% of the arterial hematocrit [41].

thumbnail
Fig 2. Representative LMCA relaxation-rate-change time curves measured a) in the aorta and b) and c) in the medial thigh muscle are shown using black circles.

Fig a) shows the bolus-delay-corrected arterial input function (red solid line) related to the arterial hematocrit Hcta). Fig b) demonstrates the curve fitting result with the ETM and Fig c) the result with the 2CXM (red solid lines) and individual results for the plasma fraction (blue dot-dashed line) and the interstitial contribution (green dotted line). Obviously, the data are much better fitted using the 2CXM. Taking bolus broadening into account, the 2CXM yields a significantly larger area under the curve for the plasma contribution compared to the ETM, where the plasma compartment is merely the AIF scaled down with the plasma volume. As a result of the larger blood plasma fraction, the interstitial contribution using the 2CXM is lower, especially during the CA uptake period.

https://doi.org/10.1371/journal.pone.0170841.g002

Fig 2b) shows ΔR(t) of the fit of the medial thigh and the fit of ETM to ΔR(t) data. Also shown are the blood plasma (blue dashed line) and the interstitial contribution (green dots). The ETMs vascular contribution is the AIF downscaled by the factor vp.

Two-Compartment Exchange Model (2CXM).

A more general model for the distribution of contrast agent in tissue is the two-compartment exchange model [1, 2]. Unlike the ETM, the 2CXM accounts for broadening of the AIF in the vascular compartment and can be described by the following two mass balance equations: (5) (6)

The total tissue concentration is calculated as (7)

Here, ce is the interstitial CA concentration. Fig 2c) shows ΔR(t)1 measured using LMCA and the fit of the 2CXM in comparison to ETM to the same data.

Bolus Deconvolution (BD).

To describe the distribution of the BPCA in the vascular system of the tissue according to the indicator dilution theory, we estimated the tissue blood concentration, cb, by convolution of the first 45 seconds of the AIF with a single exponential [42]: (8) where F is blood perfusion and H(t) the residue function with the vascular mean transit time, MTT: (9) and the blood volume is calculated via the central volume theorem [42]: (10)

Factor ξ in Eq (8) is a proportionality constant which depends on the difference in hematocrit levels between capillaries and large vessels. It compensates for the fact that only the plasma volume is accessible to the contrast agent. Technically, it also depends on the density of the tissue, which is set to 1.0 g/mL in this study. In this way we can assume: (11)

To calculate the AIF ca(t) for the capillary compartment we corrected for delay Δt and dispersion times 1/β: (12) where (13) is the vascular transport function that describes bolus dispersion during effective transit time 1/β from the site of AIF measurement to the entry of the particular region of interest. Details of this method can be found for example in [4346]. Fig 3a presents relaxation rate changes, ΔR1(t), of the measured and dispersion-corrected AIF. Fig 3b presents an example of the BD fit to the blood tissue ΔR1(t) curve measured in the medial thigh muscles of intravascular contrast agent enhancement in the tissue after bolus injection.

thumbnail
Fig 3. BPCA data recorded from CA-induced time-dependent relaxation rate changes in a) the aorta (related to the arterial hematocrit level Hcta)) and b) the medial thigh muscle (black circles) of the same experiment as the examples in Fig 2.

Additionally, in a) the time delay and bolus-dispersion-corrected AIF and in b) one example of the fitting results with the BD method (red solid lines) is shown. As indicated by the statistical results (Table 1), vb is determined lower by BD compared with 2CXM (Fig 2) and EqMRI (Fig 4).

https://doi.org/10.1371/journal.pone.0170841.g003

Equilibrium MRI (EqMRI).

Starting 40 seconds after bolus arrival, both the concentration-time curves of the BPCA-AIF and the curve of the tissue blood were averaged over a period of 20 seconds. In this period, we assumed an approximate equilibrium of contrast agent concentration. To estimate the blood volume, these two averages were related to each other [47]: (14) with ξ as defined in Eq (11). Fig 4 shows the method based on the same data as in Fig 3 for the AIF (a) and the tissue blood signal (b). Here, the red solid lines represent the mean values of the relaxivity rate change over an interval of 20 sec, starting 40 sec after bolus arrival.

thumbnail
Fig 4. For the EqMRI method, the same BPCA relaxation rate changes as in Fig 3 are shown as black circles.

No correction with respect to the arterial hematocrit level was performed at this point. Red solid lines represent the estimated average equilibrium states of a) the AIF in the aorta and in b) the medial thigh muscle (black circles) according to Eq (14) are shown.

https://doi.org/10.1371/journal.pone.0170841.g004

Curve Fitting

To produce an approximation of the relaxation rate change time curve information that would have been obtained by sampling the signal at a higher rate, we performed temporal upsampling to 0.1 sec by linear interpolation. This procedure was carried out to propagate the model fit flexibility by a higher possible temporal interframe correspondence between the estimated AIF, , and the tissue time course, ct(t). For both model fits, ETM and 2CXM, we used the first ten min of the relaxation-rate-change time curves.

We implemented the curve fitting algorithm in MATLAB 2011b (The MathWorks, Natick, Massachusetts, USA) and applied MATLAB’s constrained nonlinear optimization algorithm (fmincon) with a sequential quadratic programming method. A multi-start method with 1,000 starting points was used to find the global optimal solution for the set of model parameters. The boundaries of the parameter space were set to a wide range and were set the same for all models. The starting value of the time delay, Δt, was estimated from the individual bolus arrival time (BAT).

Statistical Analysis

Statistical analysis was performed using Microsoft Excel 2010 (Microsoft, Redmond, Washington, USA) and MATLAB R2011b. All results were expressed as medians with interquartile ranges, IQR (the difference between third and first quartile), as variances. Correlations were calculated using Pearson (rP) and Spearman (rS) correlation coefficients considering p < 0.05 to indicate significant differences.

Results

Isolectin staining of the medial thigh muscle labeling endothelium enabled determination of the vascular area (Fig 1). A clear separation of the different compartments is apparent. However, owing to collapse of blood vessels due to the disappearance of blood pressure, this method most likely underestimates the in vivo blood volume. The percentage of the segmented vascular area relative to the total muscle area was compared to the in vivo blood volume determined by MRI, see Table 1. Table 1 and Fig 5 present the vb values obtained with the two histological (IHVS and MVDE) and with four different MRI techniques (BD, EqMRI, ETM, and 2CXM) in different muscle groups [46] of the pigs’ hind legs.

thumbnail
Table 1. Median values of the model parameter vb with first (Q1) and third quartiles (Q3) and interquartile ranges (IQR) obtained with the different models and methods in the different skeletal muscle regions of the pigs’ hind legs.

Also shown are the mean values of the contrast-to-noise ratio (CNR) of the CA time courses for each muscle region. The mean CNRs of the AIFs were 80 ± 40 (92 ± 37) for the BPCA (LMCA) measurements, respectively.

https://doi.org/10.1371/journal.pone.0170841.t001

thumbnail
Fig 5. Box plots of the model parameter vb obtained with the different models and methods in the different skeletal muscle regions of the pigs’ hind legs.

https://doi.org/10.1371/journal.pone.0170841.g005

For the respective muscle areas, the different methods yield comparable vb values. In particular, there is good agreement between MRI and histological MVDE. One exception are the ETM results, which are in a range of only about 10-20% of the results obtained with the different MRI methods investigated. Although the 2CXM coincides in median and mean values with those of the two BPCA methods and MVDE, it yields high variances. Overall, the highest median values were found for the medial thigh muscles. The lowest values were obtained for the cranial and lateral thigh muscles.

In the medial thigh muscle, histological measurements yielded a median 2% and a median 1.2%. The three methods EqMRI, BD and 2CXM yielded higher volumes of 2.3%, 2.4% and 2.6%, respectively. The medians of MVDE (IHVS) were found to be at lower levels of 1.1% (0.7%) to 1.5% (1.0%) in the cranial and lateral thigh muscles and in the lower leg. For all muscle areas, much lower median values were obtained with the ETM, ranging from 0.1% (cranial and lateral thigh) to 0.4% (medial thigh). Histology yielded the lowest variance, expressed by the interquartile range (IQR), in all muscle areas. In the medial thigh, for example, MVDE (IHVS) IQR was 0.7% (0.4%) versus 1.7%, 2.2% and 3.8% for BD, EqMRI and 2CXM, respectively. In the other muscle groups, only the intravascular methods, BD and EqMRI, yielded IQRs that were partially as low as those of histology (i.e., in the cranial thigh).

Each of the four median value pairs, measured in the muscle areas of medial, cranial, lateral thigh and lower leg, were correlated for the different measuring methods. Significantly high Pearson correlation coefficients were only found for BD and EqMRI (rP = 0.99, pP < 0.01), for MVDE and 2CXM (rP = 0.99, pP < 0.01), and for IHVS and ETM (rP = 0.96, pP < 0.05). Table 2 presents the Spearman correlation coefficients for the individual values of the 9 MRI experiments for the different muscle areas and for the comparisons of MRI methods. In medial thigh muscle, significant correlations between all methods were observed. Correlation was highest between the two BPCA methods, EqMRI and BD (rS = 0.95, pS < 0.001), and lowest between BD and ETM (rS = 0.75, pS < 0.05). Except for the pelvis, the correlation between EqMRI and BD was very high and clearly significant for all muscle segments, with values up to rS = 1.0. In all other muscle regions, no significant correlation was detected between the ETM and the other MRI methods. An exception was the measurement in the pelvis, where a correlation between the ETM and the 2CXM and between the ETM and EqMRI of both rS = 0.77 (pS < 0.05) was maintained. Between the intravascular contrast agent methods and the 2CXM, significant correlations were revealed for all muscle regions, with values of rS = 0.78 (pS < 0.05) to rS = 0.89 (pS < 0.01). The correlation between the combined 5 × 12 values of all muscle areas in all experiments yielded significant correlations between all MRI methods with values of rS = 0.47 (pS < 0.01) between the ETM and the 2CXM and rS = 0.94 (pS < 10−20) between BD and EqMRI.

thumbnail
Table 2. Spearman correlation coefficients of the individual results of the four MRI methods for the muscle groups in the hind legs of the pigs and Wicoxon rank sum test results between the different MRI methods and between MRI and histology.

https://doi.org/10.1371/journal.pone.0170841.t002

We used the Wilcoxon rank sum test to identify significant differences between the median values for vb of different MRI techniques (pW < 0.05 indicates that the test rejects the null hypothesis of equal medians at the 5% significance level). For the comparison of ETM results with the results of the other methods, no significant correspondence between the medians was detected with one exception: there was a match between the ETM and 2CXM in the pelvis. The last four columns in Table 2 show the Wilcoxon signed rank test p-values for determination of significant matches between the median vb results of MVDE histology and all MRI methods. Comparison of histological medians with those of the 2CXM yielded no significant differences for any of the muscle areas investigated. For the ETM, however, the medians were significantly different from those of histology for all muscle groups. Significant differences were found in the cranial thigh muscles for EqMRI and both in the cranial thigh muscles and in the lower log for BD.

Discussion

In the present study, we found good agreement between the results obtained with MRI and histology and between the results obtained using the different methods and models with the exception of IHVS histology and the ETM. For all techniques and methods, consistently different vb values were found in the different muscle areas investigated. The ETM yielded unrealistic low blood volumes of less than one percent.

Very good correlations between the median blood volumes in all experiments with good conformity of absolute values in a plausible range and with low variance were obtained for the two BPCA methods, BD and EqMRI. Comparable vb medians were obtained with MVDE histology, BD, EqMRI, and the 2CXM in the different muscle groups. Significant correlations were found for the median values measured in the four different muscle groups with MVDE (IHVS) histology and the 2CXM (ETM).

The MRI methods, however, yielded much larger vb IQRs than histology, and the differences were especially pronounced for use of the 2CXM.

Table 3 lists average blood volume values reported in the literature for different skeletal muscles in different regions and obtained with different methods of analysis. For data obtained by MRI, the contrast agents and imaging techniques used by the investigators are provided. Because some authors do not report the volume of blood but the plasma volume as a result, we calculated the missing volume for all studies using the assumptions mentioned in the present article (vp = vb(1 − Hctt), where Hctt = 0.2). Reported average vb values range from 1.5% (measured by MRI in the posterior hind limb) to approx. 5% (measured by MRI in the pectoral muscle and neck of humans). Our results are consistent with the literature in that different muscle regions have different blood volumes and in that the volumes measured are also roughly comparable. In other muscle regions, e.g., in [48], vb = 2.5% was obtained in the anterior leg using the Patlak model and an intermediate contrast agent (Gadomer), which roughly corresponds to the medial thigh muscle in our study, where we found vb = 2.6% using the 2CXM, and in the dorsal hind leg vb = 1.5%, which corresponds to the lateral and cranial thigh muscle in our study with vb = 1.1 or 1.2% with the 2CXM. As in the studies of Ruotsalainen and Raitakari [49, 50], we found higher vb values in the anterior femoral region (medial thigh muscles). The higher vb values in the anterior muscle area near the femoral artery (both in our study and those of others and for MRI and histology) might be attributable to the higher proportion of larger vessels in this area.

thumbnail
Table 3. Comparison of blood and plasma volume fractions of skeletal muscle of different species reported in the literature.

https://doi.org/10.1371/journal.pone.0170841.t003

An element of uncertainty in the determination of vp is already introduced with the choice of systemic or arterial hematocrit. Systemic hematocrit is typically determined in venous blood. However, in pharmacokinetic modeling, i.e., in Eq (14), the arterial hematocrit is required, which is slightly lower than venous Hct. True arterial hematocrit levels are unknown, particularly in clinical trials of humans. Moreover, although the contrast agents only enter the plasma volume, some studies did not take into account the difference of tissue hematocrit and systemic hematocrit. The impact of the ratio of tissue to arterial hematocrit is described in Eq (11) for the bolus deconvolution method and in Eq (14) for the equilibrium method. Using the same values for both parameters would yield approx. 30% lower blood volumes. Measurement of individual arterial hematocrit would be useful since individual hematocrit levels may differ even among animals of the same sex, weight and breed and thus affect MRI blood volume estimates [40]. Reference [40] (p. 44, table below, row “Deutsche Landrasse”) reports a standard deviation for Hcta levels measured in 50 individuals of 0.03, mean(±2SD) of 0.36(±0.06) and minimal (maximum) Hcta of 0.29 (0.44). To estimate the influence of the lack of knowlege about individual Hcta levels on the variability of our vb results, we assume microvascular Hct to be independent of arterial Hct and exemplarily calculate median vb values estimated with EqMRI to 2.3% for Hcta = 0.42 and 2.8% for Hcta = 0.3 instead of vb = 2.4 with Hcta = 0.4 (Table 1). However, omission of this measurement results in a small estimated difference of 0.5% compared to the IQRs shown in Table 1 (2.2% in the considered exemplarily case).

Hcta was chosen based on the veterinary literature for pigs of similar breed and weight [39, 40]. Since intercapillary hematocrit can be as low as 20-40% of the systemic hematocrit (see [41] and refrences therein), intercapillary hematocrit has a stronger influence than tissue hematocrit in determining capillary blood volume. Exact determination of capillary blood volume using DCE-MRI would require exclusion of small vessels such as venules and arterioles. In the present study, all vessels were included in the analysis because current technology does not detect noncapillary vessels of sub-voxel size. On the other hand, maximum comparability between experiments was aimed at. An average vessel diameter of 8 μm for MVDE was used in the present study. Reports in the literature describe capillary diameters between 5 and 10 μ.

Equating arterial and tissue hematocrit in Eqs (1) and (5) of the two-compartment model mass equations for the two LMCA methods leads to an underestimation of vb. For clinical application of tracer kinetic methods, the problem of inserting the correct hematocrit into the equations for each voxel is even more difficult, as hematocrit in tumorous tissue is highly inhomogeneous and might differ markedly from levels in healthy tissue.

Gadofosveset trisodium was used as intravascular contrast agent for blood volume determination based on the indicator dilution theory. It is a clinically approved gadolinium-based MRI contrast agent used as a blood pool contrast agent due to its reversible binding to endogenous human serum albumin and its high longitudinal relaxivity at low magnetic field strengths [35]. At low concentrations, 90% of the agent binds to human serum [58]. Thus, most of the agent remains within the vascular space for the first minute after administration, with only a small proportion of up to 10% undergoing extravasation. However, in pigs, binding of this contrast agent to albumin is slightly lower, 83-87%, but still high compared with other animals [59]. Gadofosveset binding to albumin leads to a marked increase in the relaxation rate [35]. Therefore, extravasation of unbound gadofosveset is negligible in the determination of physiological parameters using BPCA methods in healthy tissue.

However, tumor vasculature is impaired and the endothelial wall of tumor vessels are more permeable. Although our study is motivated by tumors, the results found in healthy muscle tissue cannot be directely transferred to estimations of these parameters in tumor tissue.

Donahue et al. described the relationship between vascular proton exchange rates and the accuracy and precision of tissue blood volume estimates using intravascular T1 contrast agents [60]. To minimize blood volume underestimation in fast exchange models they propose to use spoiled gradient echo pulse sequences with short TRs, which should be much smaller than the intravascular postcontrast T1. Moreover, the flip angle should not be too small. Since in our experiments T1 was on the order of 1500 ms, α = 30° and TR = 2.7 ms, artifacts due to capillary-interstitial proton exchange are minimal. However, the high contrast concentration during first pass of nonextravasating intravascular CA may result in a state closer to the slow proton exchange regimen and thus lead to a flattened bolus and vb underestimation. These theoretical predictions are in good agreement with our experimental findings. The median values obtained with BD were on average 20% below those provided by EqMRI. Another factor contributing to these results, however, might be an overcorrection for dispersion in the BD case.

Schwarzbauer et al. proposed a steady-state intravascular CA quantification method of blood volume, which basically corresponds to the method termed EqMRI in our study [47]. For blood volume determination in the myocardium of rats overestimation resulting from T1 differences between blood and extravascular space, due to exclusive proton magnetization exchange between these spaces, was taken into account [61, 62]. The resulting perfusion dependence of T1 images acquired with a 2D FLASH sequence was used to correct regional blood volume. For low perfused tissues as investigated in the present study, the perfusion dependence of magnetization alteration can be neglected because, due to the long mean transit times, magnetization is already at the arterial end of the capillaries in steady state.

Because the site where the AIF is measured is close to the edge of the field of view, degradation of measurement accuracy through inflow effects cannot be fully excluded. For AIF extraction in the aorta using a 3D spoiled gradient echo DCE-MRI sequence with frequency encoding gradient in axial direction, Roberts et al. recommend an optimal distance of the extraction location of the AIF from the edge of the outermost axial scan of at least 20-30 mm to avoid underestimation of blood volume due to blood inflow [63]. The distance of the FOV edge from the nearest voxels of the selected AIF region in our study averaged 17 ± 8 mm and the selected voxels stretched over an average area of 39 ± 12 mm inside the FOV. No significant systematic relationship was found between the vb results and the corresponding distances, expansion in the FOV of the AIF voxel areas or the quotient of both. However, we did not correct our data for B1 field inhomogeneities, which may have influenced both the median MRI vb value and the uncertainties.

There were at least 30 minutes between the MRI examinations with the two contrast agents, LMCA and BPCA. Because gadoteric acid has a half-life of approx. 1.5 hours, we may assume that the effect of ongoing degradation of gadoteric acid during the 50-second BPCA measurement is negligible.

The ETM disregards bolus dispersion of the vascular contribution, leading to significant underestimates of the blood volume. On the other hand, the 2CXM has 5 model parameters including the time delay and may therefore be prone to overfitting. This would explain the large variance of vb obtained with this model. The BD additionally takes into account bolus dispersion, making it theoretically more prone to overestimations of vb and to a greater variance of results. This expectation, however, was not confirmed by our results.

The duration of the image acquisition period for LMCA models influences the results of curve fitting [64, 65]. Analyzing the results of all the model parameters for different acquisition times of both, the blood and the interstitial volume, we selected an acquisition period of 10 min. This acquisition duration (AD) provided the best fit for the 2CXM and the optimal match between the functional parameters of ETM and 2CXM. For example, in medial thigh muscle, the blood volume increased by 6% at an AD of 10 min relative to the value at AD = 6 min when using the 2CXM. The IQR, however, was reduced by 16%. On the other hand, for the ETM, the relative change in blood volume between these acquisition durations was 40% for the median and minus 5% for the IQR.

Luypaert et al. emphasize the importance of the acquisition period as well as the temporal resolution and the contrast-to-noise ratio (CNR) for the accuracy of model parameter estimation with the 2CXM [64]. They define the CNR as the ratio of the maximum tissue concentration to the standard deviation of the noise. They conclude that in order to keep the relative errors in determining the four model parameters using the 2CXM within a range of ±20%, demands must be made that cannot be met by currently available technology. However, their recommendations regarding temporal resolution (5 sec) and AD (110 sec) are met by our experimental setup. In contrast, the proposed requirement of a CNR of 40 is not met by all experiments in our study, since our LMCA CNR is in the range of 20 ± 9 (pelvis) to 42 ± 16 (medial thigh), which might be an additional explanation for the larg variations in vb.

Conclusion

Our results show good agreement between the median values obtained by histology and the BPCA MRI methods and the 2CXM LMCA approach. However, the ETM yielded results that were completely different from the histological vb values. Using BPCA methods for measuring blood volume has the crucial advantage of simple implementation, very short acquisition times, and a stable and accurate measurement. While LMCA models provide excellent curve fits and can in principle determine more physiological parameters than BPCA methods, they yield more inaccurate individual results.

Supporting Information

S2 File. AIF and tissue data.

The files contain the time points and the relaxation rate changes of the AIF and the five skeletal muscle regions of the pigs hind limb.

https://doi.org/10.1371/journal.pone.0170841.s002

(ZIP)

Author Contributions

  1. Conceptualization: LL.
  2. Data curation: AS SH LL.
  3. Formal analysis: SH AS.
  4. Funding acquisition: LL.
  5. Investigation: LL MM AS SH DM.
  6. Methodology: LL SH AS.
  7. Project administration: LL.
  8. Resources: WS MK HAB.
  9. Software: LL SH.
  10. Supervision: LL.
  11. Validation: AS SH.
  12. Visualization: SH AS.
  13. Writing – original draft: SH.
  14. Writing – review & editing: SH LL.

References

  1. 1. Cuenod CA, Balvay D. Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. Diagnostic and interventional imaging. 2013;94(12):1187–1204. pmid:24211260
  2. 2. Sourbron SP, Buckley DL. Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability. Physics in medicine and biology. 2012;57(2):R1–33. pmid:22173205
  3. 3. Lüdemann L, Grieger W, Wurm R, Wust P, Zimmer C. Glioma assessment using quantitative blood volume maps generated by T1-weighted dynamic contrast-enhanced magnetic resonance imaging: a receiver operating characteristic study. Acta radiologica (Stockholm, Sweden: 1987). 2006;47(3):303–310. pmid:16613313
  4. 4. Lüdemann L, Warmuth C, Plotkin M, Förschler A, Gutberlet M, Wust P, et al. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography. European journal of radiology. 2009;70(3):465–474. pmid:18359598
  5. 5. Kremser C, Trieb T, Rudisch A, Judmaier W, de Vries A. Dynamic T(1) mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis. Journal of magnetic resonance imaging: JMRI. 2007;26(3):662–671. pmid:17729365
  6. 6. Turetschek K, Preda A, Novikov V, Brasch RC, Weinmann HJ, Wunderbaldinger P, et al. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights. Journal of magnetic resonance imaging: JMRI. 2004;20(1):138–144. pmid:15221819
  7. 7. Bhujwalla ZM, Artemov D, Natarajan K, Solaiyappan M, Kollars P, Kristjansen PEG. Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. Clinical cancer research. 2003;9(1):355–362. pmid:12538488
  8. 8. Yaligar J, Thakur SB, Bokacheva L, Carlin S, Thaler HT, Rizwan A, et al. Lactate MRSI and DCE MRI as surrogate markers of prostate tumor aggressiveness. NMR in biomedicine. 2012;25(1):113–122. pmid:21618306
  9. 9. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. Journal of magnetic resonance imaging: JMRI. 1999;10(3):223–232. pmid:10508281
  10. 10. Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magnetic resonance in medicine. 2002;47(3):601–606. pmid:11870848
  11. 11. Harrer JU, Parker GJM, Haroon HA, Buckley DL, Embelton K, Roberts C, et al. Comparative study of methods for determining vascular permeability and blood volume in human gliomas. Journal of magnetic resonance imaging: JMRI. 2004;20(5):748–757. pmid:15503330
  12. 12. Henderson E, Sykes J, Drost D, Weinmann HJ, Rutt BK, Lee TY. Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents. Journal of magnetic resonance imaging: JMRI. 2000;12(6):991–1003. pmid:11105041
  13. 13. Brix G, Kiessling F, Lucht R, Darai S, Wasser K, Delorme S, et al. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magnetic resonance in medicine. 2004;52(2):420–429. pmid:15282828
  14. 14. Vaupel P, Hockel M. Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance. International journal of oncology. 2000;17(5):869–879. pmid:11029486
  15. 15. Risau W. Mechanisms of angiogenesis. Nature. 1997;386(6626):671–674. pmid:9109485
  16. 16. Johnson G, Wetzel SG, Cha S, Babb J, Tofts PS. Measuring blood volume and vascular transfer constant from dynamic, T(2)*-weighted contrast-enhanced MRI. Magnetic resonance in medicine. 2004;51(5):961–968. pmid:15122678
  17. 17. Zhu X, Li K, Jackson A. Dynamic Contrast-Enhanced MRI in Cerebral Tumours. In: Jackson A, Buckley D, Parker GM, editors. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology. Medical Radiology. Springer Berlin Heidelberg; 2005. p. 117–143. Available from: http://dx.doi.org/10.1007/3-540-26420-5_9.
  18. 18. Raatschen HJ, Fu Y, Shames DM, Wendland MF, Brasch RC. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations. Investigative radiology. 2006;41(12):860–867. pmid:17099424
  19. 19. Ah-See ML, Padhani A. Dynamic Magnetic Resonance Imaging in Breast Cancer. In: Jackson A, Buckley D, Parker GM, editors. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology. Medical Radiology. Springer Berlin Heidelberg; 2005. p. 145–173. Available from: http://dx.doi.org/10.1007/3-540-26420-5_10.
  20. 20. Versluis B, Dremmen MHG, Nelemans PJ, Wildberger JE, Schurink GW, Leiner T, et al. Dynamic contrast-enhanced MRI assessment of hyperemic fractional microvascular blood plasma volume in peripheral arterial disease: initial findings. PloS one. 2012;7(5):e37756. pmid:22662212
  21. 21. Cao Y, Shen Z, Chenevert TL, Ewing JR. Estimate of vascular permeability and cerebral blood volume using Gd-DTPA contrast enhancement and dynamic T2*-weighted MRI. Journal of magnetic resonance imaging: JMRI. 2006;24(2):288–296. pmid:16795091
  22. 22. Sourbron S, Ingrisch M, Siefert A, Reiser M, Herrmann K. Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. Magnetic resonance in medicine. 2009;62(1):205–217. pmid:19449435
  23. 23. Thompson G, Mills SJ, Coope DJ, O’Connor JPB, Jackson A. Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours. The British journal of radiology. 2011;84 Spec No 2:S127–S144. pmid:22433824
  24. 24. Server A, Orheim TED, Graff BA, Josefsen R, Kumar T, Nakstad PH. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis. Neuroradiology. 2011;53(5):319–330. pmid:20625709
  25. 25. Perles-Barbacaru AT, Berger F, Lahrech H. Quantitative rapid steady state T1 magnetic resonance imaging for cerebral blood volume mapping in mice: Lengthened measurement time window with intraperitoneal Gd-DOTA injection. Magnetic resonance in medicine. 2013;69(5):1451–1456. pmid:22760854
  26. 26. Arevalo-Perez J, Kebede AA, Peck KK, Diamond E, Holodny AI, Rosenblum M, et al. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas. Journal of neuroimagin. 2015; pmid:26707628
  27. 27. Abe T, Mizobuchi Y, Nakajima K, Otomi Y, Irahara S, Obama Y, et al. Diagnosis of brain tumors using dynamic contrast-enhanced perfusion imaging with a short acquisition time. SpringerPlus. 2015;4:88. pmid:25793147
  28. 28. Fournier L, Brasch R. The Role of Blood Pool Contrast Media in the Study of Tumor Pathophysiology. In: Jackson A, Buckley D, Parker GM, editors. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology. Medical Radiology. Springer Berlin Heidelberg; 2005. p. 39–52. Available from: http://dx.doi.org/10.1007/3-540-26420-5_3.
  29. 29. Bode G, Clausing P, Gervais F, Loegsted J, Luft J, Nogues V, et al. The utility of the minipig as an animal model in regulatory toxicology. Journal of pharmacological and toxicological methods. 2010;62(3):196–220. pmid:20685310
  30. 30. Stanton HC. Swine in cardiovascular research. Bd. 1. CRC Press; 1986. Available from: https://books.google.de/books?id=7hXgrQEACAAJ.
  31. 31. Sauerbrey A, Hindel S, Maaß M, Krüger C, Wissmann A, Kramer M, et al. Establishment of a swine model for validation of perfusion measurement by dynamic contrast-enhanced magnetic resonance imaging. BioMed research international. 2014;2014:390506. pmid:24719859
  32. 32. Hindel S, Söhner A, Maa M, Sauerwein W, Baba HA, Kramer M, et al. Validation of Interstitial Fractional Volume Quantification by Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscles. Investigative radiology. 2017;52(1):66–73. pmid:27482651
  33. 33. Mulisch M, Welsch U. Romeis Mikroskopische Technik. Springer-Verlag; 2010.
  34. 34. Maxie MG, Jubb KVF. Pathology of domestic animals. Elsevier Saunders; 2007. Available from: http://www.sciencedirect.com.ezproxy.library.uq.edu.au/science/book/9780702028236.
  35. 35. Richardson OC, Scott MLJ, Tanner SF, Waterton JC, Buckley DL. Overcoming the low relaxivity of gadofosveset at high field with spin locking. Magnetic resonance in medicine. 2012;68(4):1234–1238. pmid:22161901
  36. 36. Barrett T, Kobayashi H, Brechbiel M, Choyke PL. Macromolecular MRI contrast agents for imaging tumor angiogenesis. European journal of radiology. 2006;60(3):353–366. pmid:16930905
  37. 37. Li KL, Zhu XP, Waterton J, Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. Journal of magnetic resonance imaging: JMRI. 2000;12(2):347–357. pmid:10931600
  38. 38. Sourbron SP, Buckley DL. On the scope and interpretation of the Tofts models for DCE-MRI. Magnetic resonance in medicine. 2011;66(3):735–745. pmid:21384424
  39. 39. Nerbas E. Aktualisierung von Blutparametern beim Schwein [dissertation]. Tierärztliche Hochschule Hannover; 2008.
  40. 40. Kixmöller M. Labordiagnostische Referenzbereiche bei unterschiedlichen Schweinerassen sowie histopathologische und immunhistochemische Untersuchung von Gehirnen älterer Sauen und Eber auf transmissible spongiforme Enzephalopathie im Rahmen der TSE-Studie [dissertation]. Ludwig-Maximilians-Universität München; 2004.
  41. 41. Keller MW, Damon DN, Duling BR. Determination of capillary tube hematocrit during arteriolar microperfusion. The American journal of physiology. 1994;266(6 Pt 2):H2229–H2238. pmid:7517645
  42. 42. Østergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magnetic resonance in medicine. 1996;36(5):715–725. pmid:8916022
  43. 43. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magnetic resonance in medicine. 2000;44(3):466–473. pmid:10975900
  44. 44. Calamante F. Bolus dispersion issues related to the quantification of perfusion MRI data. Journal of magnetic resonance imaging: JMRI. 2005;22(6):718–722. pmid:16261569
  45. 45. Calamante F, Willats L, Gadian DG, Connelly A. Bolus delay and dispersion in perfusion MRI: implications for tissue predictor models in stroke. Magnetic resonance in medicine. 2006;55(5):1180–1185. pmid:16598717
  46. 46. Hindel S, Sauerbrey A, Maaß M, Maderwald S, Schlamann M, Lüdemann L. Validation of Perfusion Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using a Blood Pool Contrast Agent in Skeletal Swine Muscle. PloS one. 2015;10(6):e0128060. pmid:26061498
  47. 47. Schwarzbauer C, Syha J, Haase A. Quantification of regional blood volumes by rapid T1 mapping. Magnetic resonance in medicine. 1993;29(5):709–712. pmid:8505910
  48. 48. Cheng HLM. T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1-weighted DCE-MRI. Journal of magnetic resonance imaging: JMRI. 2007;25(5):1073–1078. pmid:17410576
  49. 49. Ruotsalainen U, Raitakari M, Nuutila P, Oikonen V, Sipilä H, Teräs M, et al. Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET. Journal of nuclear medicine. 1997;38(2):314–319. pmid:9025761
  50. 50. Raitakari M, Knuuti MJ, Ruotsalainen U, Laine H, Mäkeä P, Teräs M, et al. Insulin increases blood volume in human skeletal muscle: studies using [15O]CO and positron emission tomography. The American journal of physiology. 1995;269(6 Pt 1):E1000–E1005. pmid:8572189
  51. 51. Faranesh AZ, Kraitchman DL, McVeigh ER. Measurement of kinetic parameters in skeletal muscle by magnetic resonance imaging with an intravascular agent. Magnetic resonance in medicine. 2006;55(5):1114–1123. pmid:16598733
  52. 52. Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W. Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT–initial experience. Radiology. 1999;210(1):269–276. pmid:9885619
  53. 53. Kairento AL, Brownell GL, Schluederberg J, Elmaleh DR. Regional blood-flow measurement in rabbit soft-tissue tumor with positron imaging using the C15O2 steady-state and labeled microspheres. Journal of nuclear medicine. 1983;24(12):1135–1142. pmid:6417285
  54. 54. Senda M, Fishman AJ, Weise S, Alpert NM, Correia JA, Rubin RH, et al. Regional perfusion, oxygen metabolism, blood volume and immunoglobulin G accumulation at focal sites of infection in rabbits. European journal of nuclear medicine. 1992;19(3):166–172. pmid:1572379
  55. 55. Hjortdal VE, Hansen ES, Henriksen TB, Kjølseth D, Søballe K, Djurhuus JC. The microcirculation of myocutaneous island flaps in pigs studied with radioactive blood volume tracers and microspheres of different sizes. Plastic and reconstructive surgery. 1992;89(1):116–22; discussion 123–4. pmid:1727241
  56. 56. Linderkamp O, Berg D, Betke K, Köferl F, Kriegel H, Riegel KP. Blood volume and hematocrit in various organs in newborn piglets. Pediatric research. 1980;14(12):1324–1327. pmid:7208148
  57. 57. Eisenberg BR, Kuda AM, Peter JB. Stereological analysis of mammalian skeletal muscle. I. Soleus muscle of the adult guinea pig. The Journal of cell biology. 1974;60(3):732–754. pmid:4824293
  58. 58. Lauffer RB, Parmelee DJ, Dunham SU, Ouellet HS, Dolan RP, Witte S, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology. 1998;207(2):529–538. pmid:9577506
  59. 59. Eldredge HB, Spiller M, Chasse JM, Greenwood MT, Caravan P. Species dependence on plasma protein binding and relaxivity of the gadolinium-based MRI contrast agent MS-325. Investigative radiology. 2006;41(3):229–243. pmid:16481905
  60. 60. Donahue KM, Weisskoff RM, Chesler DA, Kwong KK, Bogdanov AA, Mandeville JB, et al. Improving MR quantification of regional blood volume with intravascular T1 contrast agents: accuracy, precision, and water exchange. Magnetic resonance in medicine. 1996;36(6):858–867. pmid:8946351
  61. 61. Bauer WR, Hiller KH, Roder F, Rommel E, Ertl G, Haase A. Magnetization exchange in capillaries by microcirculation affects diffusion-controlled spin-relaxation: a model which describes the effect of perfusion on relaxation enhancement by intravascular contrast agents. Magnetic resonance in medicine. 1996;35(1):43–55. pmid:8771021
  62. 62. Waller C, Kahler E, Hiller KH, Hu K, Nahrendorf M, Voll S, et al. Myocardial perfusion and intracapillary blood volume in rats at rest and with coronary dilatation: MR imaging in vivo with use of a spin-labeling technique. Radiology. 2000;215(1):189–197. pmid:10751486
  63. 63. Roberts C, Little R, Watson Y, Zhao S, Buckley DL, Parker GJM. The effect of blood inflow and B(1)-field inhomogeneity on measurement of the arterial input function in axial 3D spoiled gradient echo dynamic contrast-enhanced MRI. Magnetic resonance in medicine. 2011;65(1):108–119. pmid:20928889
  64. 64. Luypaert R, Sourbron S, de Mey J. Validity of perfusion parameters obtained using the modified Tofts model: a simulation study. Magnetic resonance in medicine. 2011;65(5):1491–1497. pmid:21500273
  65. 65. Luypaert R, Sourbron S, Makkat S, de Mey J. Error estimation for perfusion parameters obtained using the two-compartment exchange model in dynamic contrast-enhanced MRI: a simulation study. Physics in medicine and biology. 2010;55(21):6431–6443. pmid:20952813